ReviewRSC advances2025
Electrochemical biosensors for vancomycin monitoring in blood: advances, strategies, and future perspectives.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dual-mode carbon dots for cefuroxime monitoring in plasma.Mikrochimica acta · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vancomycin is a critical antibiotic for treating life-threatening infections caused by resistant bacteria. Due to its narrow therapeutic window and complex pharmacokinetics, regular monitoring of vancomycin levels is essential to prevent toxicity and minimize the risk of resistance development. Traditional methods for vancomycin analysis, such as chromatographic and immunoassay techniques, are often time-consuming, expensive, and sometimes lack sensitivity and specificity. Recent research has explored electrochemical biosensors as a promising alternative for rapid, cost-effective, and highly sensitive vancomycin detection. These biosensors leverage various electrode modifications and molecular recognition elements, including aptamers, graphene, gold nanoparticles, and molecularly imprinted polymers, to enhance selectivity and sensitivity. This review provides a comprehensive overview of the electrochemical methods for vancomycin detection in human and animal blood samples. It highlights different sensor designs, their advantages and limitations, and compares single-use and reusable biosensors. By analyzing the effectiveness and practicality of each approach, this review aims to guide future advancements in electrochemical biosensing for therapeutic drug monitoring.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.